Barbados vs Malta: HIV/AIDS deaths averted by antiretroviral therapy
Barbados
38.58 deaths
in 2024
Malta
37.73 deaths
in 2024
Barbados rank
139th
Malta rank
140th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Barbados
- Malta
How they compare
Barbados currently reports 38.58 deaths against 37.73 deaths in Malta, a difference of 0.85 deaths.
The two have swapped places 3 times across 35 shared years of data; in 1990 it was Malta ahead.
Barbados ranks 139th and Malta ranks 140th of 157 countries.
Barbados has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Barbados | Malta | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0.3687 deaths | 0 deaths | 0.3687 deaths | Barbados |
| 2000s | 61.49 deaths | 7.82 deaths | 53.67 deaths | Barbados |
| 2010s | 69.38 deaths | 21.94 deaths | 47.44 deaths | Barbados |
| 2020s | 43.74 deaths | 34.89 deaths | 8.85 deaths | Barbados |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Barbados or Malta?
- Barbados, at 38.58 deaths against 37.73 deaths in Malta as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Barbados and Malta?
- 0.85 deaths, with Barbados ahead.
- How many years of comparable data are there for Barbados and Malta?
- 35 years are reported by both, from 1990 to 2024.
- How do Barbados and Malta rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Barbados ranks 139th and Malta ranks 140th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.